Expert Bio
Ray Page, Oncologist and Hematologist
Ray Page, DO PhD FACOI FASCO is Immediate Past President and Senior Advisor at The Center for Cancer and Blood Disorders, in Fort Worth, Texas and has practiced medical oncology for 28 years. Dr. Page has been at the forefront of community oncology practice transformation participating in a variety of payment reform models, pathway systems and value-based care initiatives. As Director of Research, he has been the Principal Investigator over 300 clinical trials and is well published on a variety of cancer related topics. He has a particular interest in healthcare policy and was acknowledged as the American Society of Clinical Oncology (ASCO) Advocate of the Year.
Dr. Page actively serves many cancer related organizations including ASCO, as prior Chair of the Clinical Practice Committee, Nominating Committee, and Government Relations Committee. He is an ASCO Delegate to the AMA House of Delegates, and State Affiliate Council past chair and current Texas representative. He was past President and current Treasurer of the Texas Society of Clinical Oncology. Dr. Page also serves several committee roles with One Oncology Network.
Dr. Page has been a pioneer in Oncology Clinical Pathways development. His practice was the first community oncology practice 15 years ago to develop and implement the Via Oncology Pathways (now Elsevier CliniPath), as well as symptom-management triage pathways, which he has several publications. He has served on a number of their pathways committees. He has contributed to the publication of several ASCO Policy statements on Pathways, 340B, Site-Neutrality, Safe Handling of Hazardous Drugs, ASCO’s Patient Centered Oncology Payment model, Clinician Well-Being, ASCO Standards for Telehealth, and Biosimilars.
Dr. Page is an adjunct professor at the University of North Texas Health Science Center and has served many leadership roles there and in the local hospital systems. He has received numerous awards and honors in his career.
